China expansion Graminex has secured novel food registration in China for Rye Pollen and appointed Guangzhou Narnia Biotechnology as its distribution partner, indicating a strategic entry point into the Chinese market that can be leveraged for local partnerships, co-marketing, and channel development.

Healthcare vertical Product applications span pharmaceuticals, nutritional supplements, cosmeceuticals, and functional foods, suggesting multiple cross-selling opportunities with dietary supplement brands, wellness retailers, and pharmaceutical distributors seeking pollen extract ingredients.

Pet market potential Premium pet products are among Graminex offerings, presenting a near-term upsell path to pet care brands and pet-focused retailers looking for scientifically supported pollen-based ingredients or finished pet supplements.

Scientific leadership Recent leadership appointment of a Chief Scientific Officer and ongoing R&D orientation signal a strong foundation for technical credibility, enabling partnerships with science-driven brands, contract research, and co-development initiatives.

Strategic partnerships Past and ongoing collaborations with Idipharma and the new distributor relationship in China highlight a proven model of channel partnerships that can be expanded with contract manufacturing, private-label programs, and regional distributors in other markets.